Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1993 1
1995 2
1996 9
1997 6
1998 5
1999 1
2000 1
2001 4
2002 5
2003 6
2004 16
2005 17
2006 14
2007 19
2008 23
2009 14
2010 11
2011 6
2012 12
2013 13
2014 11
2015 16
2016 15
2017 12
2018 15
2019 8
2020 16
2021 16
2022 16
2023 22
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases.
Evans LS, Lewis KE, DeMonte D, Bhandari JG, Garrett LB, Kuijper JL, Ardourel D, Wolfson MF, Debrot S, Mudri S, Kleist K, Griffin LL, Hebb L, Sanderson RJ, Wang N, Seaberg M, Chunyk AG, Yang J, Hong Y, Maria Z, Messenheimer DJ, Holland PM, Peng SL, Rixon MW, Dillon SR. Evans LS, et al. Among authors: peng sl. Arthritis Rheumatol. 2023 Jul;75(7):1187-1202. doi: 10.1002/art.42462. Epub 2023 Apr 19. Arthritis Rheumatol. 2023. PMID: 36705554
Editorial: Artificial Intelligence for eHealth.
Gupta D, Rodrigues JJPC, Peng SL, Nguyen N. Gupta D, et al. Among authors: peng sl. Front Public Health. 2022 Mar 4;10:852840. doi: 10.3389/fpubh.2022.852840. eCollection 2022. Front Public Health. 2022. PMID: 35309212 Free PMC article. No abstract available.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: peng sl. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Progress on plant orphan genes.
Jiang ML, Lang H, Li XN, Zu Y, Zhao J, Peng SL, Liu Z, Zhan ZX, Piao ZY. Jiang ML, et al. Among authors: peng sl. Yi Chuan. 2022 Aug 20;44(8):682-694. doi: 10.16288/j.yczz.22-154. Yi Chuan. 2022. PMID: 36384667 Review.
Coffee as a dietary strategy to prevent SARS-CoV-2 infection.
Wu CS, Li YC, Peng SL, Chen CY, Chen HF, Hsueh PR, Wang WJ, Liu YY, Jiang CL, Chang WC, Wang SC, Hung MC. Wu CS, et al. Among authors: peng sl. Cell Biosci. 2023 Nov 14;13(1):210. doi: 10.1186/s13578-023-01154-9. Cell Biosci. 2023. PMID: 37964389 Free PMC article.
Foxo in the immune system.
Peng SL. Peng SL. Oncogene. 2008 Apr 7;27(16):2337-44. doi: 10.1038/onc.2008.26. Oncogene. 2008. PMID: 18391975 Review.
Surgical adhesives in ophthalmology: history and current trends.
Guhan S, Peng SL, Janbatian H, Saadeh S, Greenstein S, Al Bahrani F, Fadlallah A, Yeh TC, Melki SA. Guhan S, et al. Among authors: peng sl. Br J Ophthalmol. 2018 Oct;102(10):1328-1335. doi: 10.1136/bjophthalmol-2017-311643. Epub 2018 Mar 26. Br J Ophthalmol. 2018. PMID: 29581352 Review.
Forkhead transcription factors in immunology.
Jonsson H, Peng SL. Jonsson H, et al. Among authors: peng sl. Cell Mol Life Sci. 2005 Feb;62(4):397-409. doi: 10.1007/s00018-004-4365-8. Cell Mol Life Sci. 2005. PMID: 15719167 Review.
316 results